Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and rifampin

3,4-dihydroxyphenylacetic acid has been researched along with rifampin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Connell, MT; Patsalos, PN; Quinn, NP; Wenning, GK1
Fujimoto, Y; Hara, H; Ito, Y; Kitaichi, K; Nagai, H; Nakayama, H; Oida, Y; Shimazawa, M1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and rifampin

ArticleYear
A clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Antitubercular Agents; Dopa Decarboxylase; Homovanillic Acid; Humans; Isoniazid; Levodopa; Male; Middle Aged; Parkinson Disease; Rifampin; Tuberculosis, Pulmonary

1995
Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain.
    Brain research, 2006, Apr-12, Volume: 1082, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Body Weight; Brain; Brain Chemistry; Cell Count; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Free Radicals; Homovanillic Acid; Immunohistochemistry; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Parkinsonian Disorders; Rifampin; Tyrosine 3-Monooxygenase

2006